Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek C Angus

Showing results (521-530 of 582) with videos related to

Pageof 59
Sort By:
Critical Care Medicine|January 29, 2013
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012R Phillip Dellinger, Mitchell M Levy, Andrew Rhodes, et al.
Intensive Care Medicine|January 31, 2013
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012R P Dellinger, Mitchell M Levy, Andrew Rhodes, et al.
Critical Care Medicine|December 26, 2007
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008R Phillip Dellinger, Mitchell M Levy, Jean M Carlet, et al.
Trials|August 25, 2020
Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trialsJonathan A C Sterne, Janet Diaz, Jesús Villar, et al.
Intensive Care Medicine|March 4, 2024
Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Lancet (London, England)|January 20, 2020
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease StudyKristina E Rudd, Sarah Charlotte Johnson, Kareha M Agesa, et al.
Intensive Care Medicine|January 3, 2024
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Contemporary Clinical Trials|December 13, 2021
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 daysErin K McCreary, J Ryan Bariola, Tami Minnier, et al.
JAMA Network Open|April 12, 2022
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19Erin K McCreary, J Ryan Bariola, Richard J Wadas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Effects of Organizational Characteristics on Outcomes and Resource Use in Patients With Cancer Admitted to Intensive Care UnitsMarcio Soares, Fernando A Bozza, Luciano C P Azevedo, et al.
Pageof 59

Showing results (521-530 of 582) with videos related to

Sort By:
Pageof 59
Critical Care Medicine|January 29, 2013
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012R Phillip Dellinger, Mitchell M Levy, Andrew Rhodes, et al.
Intensive Care Medicine|January 31, 2013
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012R P Dellinger, Mitchell M Levy, Andrew Rhodes, et al.
Critical Care Medicine|December 26, 2007
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008R Phillip Dellinger, Mitchell M Levy, Jean M Carlet, et al.
Trials|August 25, 2020
Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trialsJonathan A C Sterne, Janet Diaz, Jesús Villar, et al.
Intensive Care Medicine|March 4, 2024
Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Lancet (London, England)|January 20, 2020
Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease StudyKristina E Rudd, Sarah Charlotte Johnson, Kareha M Agesa, et al.
Intensive Care Medicine|January 3, 2024
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C Angus, Kristie Bass, et al.
Contemporary Clinical Trials|December 13, 2021
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 daysErin K McCreary, J Ryan Bariola, Tami Minnier, et al.
JAMA Network Open|April 12, 2022
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19Erin K McCreary, J Ryan Bariola, Richard J Wadas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Effects of Organizational Characteristics on Outcomes and Resource Use in Patients With Cancer Admitted to Intensive Care UnitsMarcio Soares, Fernando A Bozza, Luciano C P Azevedo, et al.
Pageof 59